A meta-analysis for C-X-C chemokine receptor type 4 as a prognostic marker and potential drug target in hepatocellular carcinoma

  • Fei Hu, Lin Miao, Yu Zhao, Yuan-Yuan Xiao, Qing Xu
  • Drug Design Development and Therapy, July 2015, Taylor & Francis
  • DOI: 10.2147/dddt.s86032

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.2147/dddt.s86032